Endpoints News· @endpts · X·· 20 小时前AI 评分22
AI 导读
Stipple Bio 正在设计 ADC，靶向仅存在于癌细胞上的位点，不伤及健康组织，从胰腺癌开始。为何入选 Endpoints 11：https://endpoints.news/endpoints-11-2026-winner-stipple-bio-is-taking-precision-to-the-next-level/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=
正文
Stipple Bio is designing ADCs that hit spots found only on cancer cells, sparing healthy tissue, starting with pancreatic cancer. Why it made the Endpoints 11: https://endpoints.news/endpoints-11-2026-winner-stipple-bio-is-taking-precision-to-the-next-level/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=
来源：Endpoints News · x.com